Unveiling the Gastric Microbiota: Implications for Gastric Carcinogenesis, Immune Responses, and Clinical Prospects

Overview

Journal J Exp Clin Cancer Res

Publisher Biomed Central

Specialty Oncology

Date 2024 Apr 19

PMID 38641815

Authors

Zhiyi Liu

Dachuan Zhang

Siyu Chen

Affiliations

Soon will be listed here.

Abstract

High-throughput sequencing has ushered in a paradigm shift in gastric microbiota, breaking the stereotype that the stomach is hostile to microorganisms beyond H. pylori. Recent attention directed toward the composition and functionality of this 'community' has shed light on its potential relevance in cancer. The microbial composition in the stomach of health displays host specificity which changes throughout a person's lifespan and is subject to both external and internal factors. Distinctive alterations in gastric microbiome signature are discernible at different stages of gastric precancerous lesions and malignancy. The robust microbes that dominate in gastric malignant tissue are intricately implicated in gastric cancer susceptibility, carcinogenesis, and the modulation of immunosurveillance and immune escape. These revelations offer fresh avenues for utilizing gastric microbiota as predictive biomarkers in clinical settings. Furthermore, inter-individual microbiota variations partially account for differential responses to cancer immunotherapy. In this review, we summarize current literature on the influence of the gastric microbiota on gastric carcinogenesis, anti-tumor immunity and immunotherapy, providing insights into potential clinical applications.

Citing Articles

New perspectives on gastric disorders: the relationship between innate lymphoid cells and microbes in the stomach.

Yan Y, Satoh-Takayama N Cell Mol Life Sci. 2025; 82(1):113.

PMID: 40074935 PMC: 11904066. DOI: 10.1007/s00018-025-05632-w.

Multiomics insights into BMI-related intratumoral microbiota in gastric cancer.

Liu K, Jiang Z, Ma Y, Xia R, Zheng Y, Yin K Front Cell Infect Microbiol. 2025; 15:1511900.

PMID: 40041144 PMC: 11876552. DOI: 10.3389/fcimb.2025.1511900.

infection and inflammatory events: the extracellular vesicle-connect in driving gastrointestinal tract cancers.

Bawali P, Brahma A, Rana S, Pal A, Bhattacharyya A Front Med (Lausanne). 2024; 11:1444242.

PMID: 39610678 PMC: 11602329. DOI: 10.3389/fmed.2024.1444242.

Molecular Mechanism for Malignant Progression of Gastric Cancer Within the Tumor Microenvironment.

Matsuoka T, Yashiro M Int J Mol Sci. 2024; 25(21).

PMID: 39519285 PMC: 11546171. DOI: 10.3390/ijms252111735.

Interactions between Dietary Antioxidants, Dietary Fiber and the Gut Microbiome: Their Putative Role in Inflammation and Cancer.

Munteanu C, Schwartz B Int J Mol Sci. 2024; 25(15).

PMID: 39125822 PMC: 11311432. DOI: 10.3390/ijms25158250.

References

Kang W, Jia Z, Tang D, Zhang Z, Gao H, He K . Facilitates Apoptosis, ROS Generation, and Inflammatory Cytokine Production by Activating AKT/MAPK and NF-B Signaling Pathways in Human Gingival Fibroblasts. Oxid Med Cell Longev. 2019; 2019:1681972. PMC: 6815639. DOI: 10.1155/2019/1681972. View

Malfertheiner P, Camargo M, El-Omar E, Liou J, Peek R, Schulz C . Helicobacter pylori infection. Nat Rev Dis Primers. 2023; 9(1):19. PMC: 11558793. DOI: 10.1038/s41572-023-00431-8. View

Ndegwa N, Ploner A, Andersson A, Zagai U, Andreasson A, Vieth M . Gastric Microbiota in a Low-Helicobacter pylori Prevalence General Population and Their Associations With Gastric Lesions. Clin Transl Gastroenterol. 2020; 11(7):e00191. PMC: 7431247. DOI: 10.14309/ctg.0000000000000191. View

Li Y, Jin Y, Zhang J, Pan H, Wu L, Liu D . Recovery of human gut microbiota genomes with third-generation sequencing. Cell Death Dis. 2021; 12(6):569. PMC: 8172872. DOI: 10.1038/s41419-021-03829-y. View

Xue L, Mao X, Liu X, Gao H, Chen Y, Dai T . Activation of CD3 T cells by Helicobacter pylori DNA vaccines in potential immunotherapy of gastric carcinoma. Cancer Biol Ther. 2019; 20(6):866-876. PMC: 6605983. DOI: 10.1080/15384047.2019.1579957. View

Llorca L, Perez-Perez G, Urruzuno P, Martinez M, Iizumi T, Gao Z . Characterization of the Gastric Microbiota in a Pediatric Population According to Helicobacter pylori Status. Pediatr Infect Dis J. 2016; 36(2):173-178. DOI: 10.1097/INF.0000000000001383. View

Png C, Lee W, Chua S, Zhu F, Yeoh K, Zhang Y . Mucosal microbiome associates with progression to gastric cancer. Theranostics. 2022; 12(1):48-58. PMC: 8690935. DOI: 10.7150/thno.65302. View

Kwon S, Park J, Kim K, Yoon J, Cho Y, Lee B . Human gastric microbiota transplantation recapitulates premalignant lesions in germ-free mice. Gut. 2021; 71(7):1266-1276. DOI: 10.1136/gutjnl-2021-324489. View

Fu K, Cheung A, Wong C, Liu W, Zhou Y, Wang F . Streptococcus anginosus promotes gastric inflammation, atrophy, and tumorigenesis in mice. Cell. 2024; 187(4):882-896.e17. DOI: 10.1016/j.cell.2024.01.004. View

10.

Horii M, Matsushita T . Regulatory B cells and T cell Regulation in Cancer. J Mol Biol. 2020; 433(1):166685. DOI: 10.1016/j.jmb.2020.10.019. View

11.

He J, Hu W, OuYang Q, Zhang S, He L, Chen W . Helicobacter pylori infection induces stem cell-like properties in Correa cascade of gastric cancer. Cancer Lett. 2022; 542:215764. DOI: 10.1016/j.canlet.2022.215764. View

12.

Koh V, Chakrabarti J, Torvund M, Steele N, Hawkins J, Ito Y . Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids. Cancer Lett. 2021; 518:59-71. PMC: 8606306. DOI: 10.1016/j.canlet.2021.06.007. View

13.

Thrift A, Wenker T, El-Serag H . Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 2023; 20(5):338-349. DOI: 10.1038/s41571-023-00747-0. View

14.

Codolo G, Fassan M, Munari F, Volpe A, Bassi P, Rugge M . HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response. Cancer Immunol Immunother. 2011; 61(1):31-40. PMC: 11028894. DOI: 10.1007/s00262-011-1087-2. View

15.

Nyangahu D, Lennard K, Brown B, Darby M, Wendoh J, Havyarimana E . Disruption of maternal gut microbiota during gestation alters offspring microbiota and immunity. Microbiome. 2018; 6(1):124. PMC: 6035804. DOI: 10.1186/s40168-018-0511-7. View

16.

Zmora N, Suez J, Elinav E . You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2018; 16(1):35-56. DOI: 10.1038/s41575-018-0061-2. View

17.

Chaput N, Lepage P, Coutzac C, Soularue E, Le Roux K, Monot C . Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab. Ann Oncol. 2019; 30(12):2012. DOI: 10.1093/annonc/mdz224. View

18.

Andrews M, Duong C, Gopalakrishnan V, Iebba V, Chen W, Derosa L . Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade. Nat Med. 2021; 27(8):1432-1441. PMC: 11107795. DOI: 10.1038/s41591-021-01406-6. View

19.

Peng C, Ouyang Y, Lu N, Li N . The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances. Front Immunol. 2020; 11:1387. PMC: 7338561. DOI: 10.3389/fimmu.2020.01387. View

20.

Imai S, Ooki T, Murata-Kamiya N, Komura D, Tahmina K, Wu W . Helicobacter pylori CagA elicits BRCAness to induce genome instability that may underlie bacterial gastric carcinogenesis. Cell Host Microbe. 2021; 29(6):941-958.e10. DOI: 10.1016/j.chom.2021.04.006. View